Page last updated: 2024-11-05

xylazine and Glial Cell Tumors

xylazine has been researched along with Glial Cell Tumors in 1 studies

Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.

Research Excerpts

ExcerptRelevanceReference
"In the present study we demonstrate that the glycolysis of the tumour 9L glioma, in vivo, may be manipulated with ketamine/xylazine combinations of anaesthetics."3.69The importance of choice of anaesthetics in studying radiation effects in the 9L rat glioma. ( Biaglow, JE; Kim, S; Manevich, Y; Pavlovic, M; Wróblewski, K, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pavlovic, M1
Wróblewski, K1
Manevich, Y1
Kim, S1
Biaglow, JE1

Other Studies

1 other study available for xylazine and Glial Cell Tumors

ArticleYear
The importance of choice of anaesthetics in studying radiation effects in the 9L rat glioma.
    The British journal of cancer. Supplement, 1996, Volume: 27

    Topics: Anesthetics; Animals; Blood Glucose; Glioma; Hydrogen-Ion Concentration; Ketamine; Male; Phosphates;

1996